NCT00991692已完成不适用
A Multisite Trial of ACQUIREc Therapy
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 18
- 试验地点
- 1
研究概览
简要总结
A multisite trial to testing different dosage levels of a systematic form of Pediatric Constraint-Induced (CI) Therapy called ACQUIREc Therapy. The high dosage treatment involved 6 hours of daily therapy services for 21 days. This was compared to a moderate dosage level of 3 hours of daily therapy services for 21 days. It was hypothesized that children receiving the higher therapy dosage would have greater and more clinically significant benefits from ACQUIREc Therapy but that both groups of children would benefit from the therapy services.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Factorial
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 3 Years 至 8 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Children 3-6 years of age
- •Hemiparetic CP
排除标准
- •No prior CI therapy treatments
- •No Botox for 6-months
研究组 & 干预措施
Treatment dosage levels examined
Experimental
干预措施: Therapy services (ACQUIREc Therapy) (Other)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)Allergic RhinoconjunctivitisChronic UrticariaNCT01081574Faes Farma, S.A.36
已完成
1 期
A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity DisorderAttention-deficit Hyperactivity DisorderNCT04786730Otsuka Pharmaceutical Development & Commercialization, Inc.50
招募中
1 期
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive TumorsRhabdomyosarcomaLymphomaGISTSomatostatin Receptor PositiveNETsSolid TumorCNS TumorsPeripheral Primitive Neuroectodermal TumorNCT06441331ITM Solucin GmbH20
招募中
不适用
Recognition of Acquired Competencies: Does is positively effect empowerment and vocational functioning in people with vulnerabilities?Psychosiocial problemsVulnerabilitiesLong-term unemploymentMensen met grote afstand tot de arbeidsmarkt vanwege kwetsbaarhedenNL-OMON26031Trimbos Institute – Netherlands Institute of mental health and addiction300
已完成
3 期
Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving DialysisKidney DiseaseNCT00111098Amgen150